Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
VEGFR-1 inhibitor
DRUG CLASS:
VEGFR-1 inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
tivozanib (3)
plitidepsin (0)
SKI-G-801 (0)
tivozanib (3)
plitidepsin (0)
SKI-G-801 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
tivozanib
Sensitive: A1 - Approval
tivozanib
Sensitive
:
A1
tivozanib
Sensitive: A1 - Approval
tivozanib
Sensitive
:
A1
No biomarker
Clear Cell Renal Cell Carcinoma
No biomarker
Clear Cell Renal Cell Carcinoma
tivozanib
Sensitive: A2 - Guideline
tivozanib
Sensitive
:
A2
tivozanib
Sensitive: A2 - Guideline
tivozanib
Sensitive
:
A2
No biomarker
Kidney Cancer
No biomarker
Kidney Cancer
tivozanib
Sensitive: A2 - Guideline
tivozanib
Sensitive
:
A2
tivozanib
Sensitive: A2 - Guideline
tivozanib
Sensitive
:
A2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login